Pleuroparenchymal Fibroelastosis Associated with Crohn’s Disease: A New Aetiology?
KeywordsPleuroparenchymal fibroelastosis, Crohn’s Disease, interstitial lung disease
Pleuroparenchymal fibroelastosis (PPFE) is a relatively rare interstitial lung disease (ILD) consisting of elastofibrosis involving the subpleural parenchyma and visceral pleura with an upper lobe predominance. It can be idiopathic or associated with some forms of autoimmune disease. The authors describe the case of a 78-year-old woman with a previous diagnosis of Crohn’s disease (CD). She presented with a protracted respiratory infection (with no significant history of previous infections), and underwent high-resolution chest computerized tomography that eventually showed alterations compatible with PPFE. After exclusion of other possible underlying causes, a possible link to CD was considered. Follow-up investigation at 12 months showed clinical and radiological stability and also stable lung function under treatment with hydroxychloroquine and prednisolone. This is the first report of PPFE in the context of CD. Future studies will be important to further investigate this pathological association and its prognostic implications.
Chua F, Desai SR, Nicholson AG, Devaraj A, Renzoni E, Rice A, et al. Pleuroparenchymal fibroelastosis – a review of clinical, radiological, and pathological characteristics. Ann Am Thorac Soc 2019;6(11):1351–1359.
Martins CT, Gonçalves JR. Fronteiras do pulmão – relação com o sistema gastroenterológico. Rev Port Pneumol 2020;16(1).
Mahadeva R, Walsh G, Flower CDR, Shneerson JM. Clinical and radiologic characteristics of lung disease in inflammatory bowel disease. Eur Respir J 2000;15:41–48.
Majewski S. Pulmonary manifestations of inflammatory bowel disease. Arch Med Sci 2015;11(6):1179–1188.
Yilmaz A, Demirci NY, Ho?gün D, Üner E, Erdo?an Y, Gökçek A, et al. Pulmonary involvement in inflammatory bowel disease. World J Gastroenterol 2010;16(39):4952–4957.
Singh R, Sundaram P, Joshi JM. Upper lobe fibrosis in ulcerative colitis. J Assoc Physicians India 2003;51:515–517.
Kinoshita Y, Watanabe K, Ishii H, Kushima H, Hamasaki M, Fujita M, et al. Pleuroparenchymal fibroelastosis as a histological background of autoimmune diseases. Virchows Archiv 2019;474(1):97–104.
Rogler G, Hausmann M. Factors promoting development of< fibrosis in Crohn’s disease. Front Med 2017;4:96.
Reddy TL, Tominaga M, Hansell DM, von der Thusen J, Rassl D, Parfrey H, et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J 2012;40(2):377–385.
Cheng SKH, Chuah KL. Pleuroparenchymal fibroelastosis of the lung: a review. Arch Pathol Lab Med 2016;140(8):849–853.
Camus P, von der Thüsen J, Hansell DM, Colby TV. Pleuroparenchymal fibroelastosis: one more walk on the wild side of drugs? Eur Resp J 2014;44:289–296.
Issue: Vol 8 No 1 (view)